HealthQuest Partners II, L.P. - 18 Nov 2022 Form 4 Insider Report for Venus Concept Inc. (VERO)

Reporting relationship: 10%+ Owner
Issuer ticker: VERO
Reported as of: 18 Nov 2022
Net transaction value: +$670,000
SEC form: 4
Accepted by SEC: 22 Nov 2022, 14:56:53 UTC
Prior SEC filing: 17 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Garheng Kong as Managing Member of HealthQuest Venture Management II, L.L.C., general partner of HealthQuest Partners II, L.P

Key filing fact

HealthQuest Partners II, L.P. filed Form 4 for Venus Concept Inc. (VERO) on 22 Nov 2022.

Key facts

This page summarizes HealthQuest Partners II, L.P.'s Form 4 filing for Venus Concept Inc. (VERO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Nov 2022, 14:56.

Change

Previous filing in this sequence was filed on 17 Dec 2021.
Current net transaction value: +$670,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VERO transaction Derivative

Voting Convertible Preferred Stock

Purchase

Transaction value: $670,000
Shares: +335,000
Change %
Price: $2.00
Shares after: 335,000
Date: 18 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,350,000
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Voting Preferred Stock will convert into shares of Common Stock on a one for ten basis (i) at the option the holder or (ii) at the option of the Company within 30 days following the occurrence of certain events. The Voting Preferred Stock votes with the Common Stock on an as-converted basis. The Voting Preferred Stock does not expire.

Footnote F2

The shares are directly held by HealthQuest Partners II, L.P. ("HealthQuest"). HealthQuest Venture Management II, L.L.C. ("HQVM II"), the general partner of HealthQuest, and Garheng Kong, the managing member of HQVM II, may be deemed to have sole voting and dispositive power with respect to the shares held of record by HealthQuest. Mr. Kong and HQVM II disclaim beneficial ownership over all shares owned by HealthQuest except to the extent of any pecuniary interest therein.